Core Viewpoint - Zhendemedical has experienced a consecutive two-day trading limit increase, indicating strong market interest and potential investor confidence [1] Group 1: Stock Performance - Zhendemedical's stock reached a trading limit at 9:58 AM with a transaction volume of 453 million yuan and a turnover rate of 1.96% [1] Group 2: Corporate Governance and Strategy - The company is optimizing its corporate governance structure by introducing a stock ownership plan for core employees and establishing a mechanism for repurchasing and canceling unblocked shares, which is expected to enhance team stability [1] - Zhendemedical is also engaging in hedging activities to mitigate risks associated with raw material price fluctuations, ensuring stable production costs [1] Group 3: Industry Context - Other companies within the pharmaceutical sector are showing positive performance due to improved governance and stable business operations, contributing to a sector-wide synergy effect [1]